231 related articles for article (PubMed ID: 31389030)
1. miR-222 inhibits cardiac fibrosis in diabetic mice heart via regulating Wnt/β-catenin-mediated endothelium to mesenchymal transition.
Wang Z; Wang Z; Gao L; Xiao L; Yao R; Du B; Li Y; Wu L; Liang C; Huang Z; Li P; Zhang Y
J Cell Physiol; 2020 Mar; 235(3):2149-2160. PubMed ID: 31389030
[TBL] [Abstract][Full Text] [Related]
2. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
3. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart.
Liang C; Gao L; Liu Y; Liu Y; Yao R; Li Y; Xiao L; Wu L; Du B; Huang Z; Zhang Y
Life Sci; 2019 May; 224():12-22. PubMed ID: 30872181
[TBL] [Abstract][Full Text] [Related]
4. MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway.
Geng H; Guan J
Biochem Biophys Res Commun; 2017 Sep; 491(2):329-336. PubMed ID: 28733035
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miR-21 alleviated cardiac perivascular fibrosis via repressing EndMT in T1DM.
Li Q; Yao Y; Shi S; Zhou M; Zhou Y; Wang M; Chiu JJ; Huang Z; Zhang W; Liu M; Wang Q; Tu X
J Cell Mol Med; 2020 Jan; 24(1):910-920. PubMed ID: 31680453
[TBL] [Abstract][Full Text] [Related]
6. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
[No Abstract] [Full Text] [Related]
8. miR-448-3p alleviates diabetic vascular dysfunction by inhibiting endothelial-mesenchymal transition through DPP-4 dysregulation.
Guan GY; Wei N; Song T; Zhao C; Sun Y; Pan RX; Zhang LL; Xu YY; Dai YM; Han H
J Cell Physiol; 2020 Dec; 235(12):10024-10036. PubMed ID: 32542696
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling.
Hsu YC; Chang PJ; Ho C; Huang YT; Shih YH; Wang CJ; Lin CL
Sci Rep; 2016 Jul; 6():30575. PubMed ID: 27460630
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.
Chen XY; Lv RJ; Zhang W; Yan YG; Li P; Dong WQ; Liu X; Liang ES; Tian HL; Lu QH; Zhang MX
Oncotarget; 2016 May; 7(21):31053-66. PubMed ID: 27105518
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.
Hu M; Wang R; Li X; Fan M; Lin J; Zhen J; Chen L; Lv Z
J Cell Mol Med; 2017 Nov; 21(11):2732-2747. PubMed ID: 28444861
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury.
Wang C; Zhu H; Sun Z; Xiang Z; Ge Y; Ni C; Luo Z; Qian W; Han X
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C234-44. PubMed ID: 24898581
[TBL] [Abstract][Full Text] [Related]
13. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway.
Li H; Zhao Q; Chang L; Wei C; Bei H; Yin Y; Chen M; Wang H; Liang J; Wu Y
Lipids Health Dis; 2019 Mar; 18(1):62. PubMed ID: 30871555
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy.
Zhou Z; Wan J; Hou X; Geng J; Li X; Bai X
Cell Death Dis; 2017 Mar; 8(3):e2658. PubMed ID: 28277542
[TBL] [Abstract][Full Text] [Related]
17. The role of miR-328 in high glucose-induced endothelial-to-mesenchymal transition in human umbilical vein endothelial cells.
Chen Y; Yang Q; Zhan Y; Ke J; Lv P; Huang J
Life Sci; 2018 Aug; 207():110-116. PubMed ID: 29859985
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
19. Cdc42-interacting protein 4 silencing relieves pulmonary fibrosis in STZ-induced diabetic mice via the Wnt/GSK-3β/β-catenin pathway.
Zhang X; Liu Y; Shao R; Li W
Exp Cell Res; 2017 Oct; 359(1):284-290. PubMed ID: 28720386
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway.
Zhang ZY; Zhai C; Yang XY; Li HB; Wu LL; Li L
PLoS One; 2022; 17(8):e0273542. PubMed ID: 36001597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
